Focal Muscular Vibration in Patients With Severe Acquired Brain Injury

Status Recruiting

Clinical Trial Summary

Severe acquired brain injury (sABI) is a group of disorders that cause long-term disability. Rehabilitation is essential to counteract bed immobilization, muscle failure, pain, and sensory deficits that can affect the clinical and rehabilitation pathway of these patients. Focal muscle vibration (FMV) is a tool that uses low-amplitude, high-frequency vibrations that when applied to muscle-tendon units. This technique, administered at specific frequencies, amplitudes and durations, can generate action potentials of the same frequency as the stimulus applied to the muscle or tendon. This makes it possible to activate selected afferent fibers and stimulate targeted brain areas with persistent effects over time (long-term potentiation). Regarding the effect of counteracting vibration spasticity, FMV is able to inhibit the reflex arc and induce reciprocal inhibition of functional agonist muscle. In addition, the strong proprioceptive stimulus generated by vibration is able to reach the primary motor and somatosensory cortex, enhancing cortical mechanisms that regulate co-contraction between agonist and antagonist muscles, thereby reducing muscle tone and joint stiffness. In many studies, this technique has been shown to be effective in reducing pain and joint stiffness by improving muscle contraction and motor control.

Clinical Trial Description

The present study aims to analyze the effects of focal muscle vibration in patients with sABI. This study is innovative for the setting, as it will take place for the first time within a neurorehabilitation hospital ward, for the intensity of the treatment as patients will undergo daily treatment sessions, for longer periods than protocols so far in the scientific literature. Finally, the cortical effects of the vibratory stimulus will be analyzed through the analysis of cortical neurophysiological correlates ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05464160
Study type	Interventional
Source	Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Contact	Letizia Castelli, MS
Phone	+390630154382
Email	letizia.castelli@policlinicogemelli.it
Status	Recruiting
Phase	N/A
Start date	October 15, 2021
Completion date	October 31, 2024

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT05542108` - Adding Motion to Contact: A New Model for Low-cost Family Centered Very-early Onset Intervention in Very Preterm-born Infants	N/A
Completed	`NCT03400904` - Extubation Strategies in Neuro-Intensive Care Unit Patients and Associations With Outcome.
Completed	`NCT06073145` - Transcranial Doppler Using Wearable Ultrasound Patch
Recruiting	`NCT03899532` - Remote Ischemic Conditioning in Traumatic Brain Injury	N/A
Recruiting	`NCT06010823` - Safety and Efficacy Evaluation of the Robotic Enhanced Error Training of Upper Limb Function in Post-stroke and Post TBI Participants	N/A
Not yet recruiting	`NCT05833568` - Five-day 20-minute 10-Hz tACS in Patients With a Disorder of Consciousness	N/A
Withdrawn	`NCT04288076` - The Brain and Lung Interaction (BALI) Study	N/A
Completed	`NCT03162484` - Physical Activity and Chronic Acquired Brain Injury	N/A
Not yet recruiting	`NCT02756585` - Computed Tomography Perfusion in Patients With Severe Head Injury	N/A
Terminated	`NCT01430988` - Observational Study of the BrainScope® Ahead™ M-100 in UK Emergency Department Patients With Head Injury	N/A
Completed	`NCT01093053` - Mind-Body Skills Groups for the Treatment of War Zone Stress in Military and Veteran Populations	N/A
Completed	`NCT00975338` - The LETS Study: A Longitudinal Evaluation of Transition Services
Completed	`NCT00878631` - Feasibility Trial of Traumatic Brain Injured Patients Randomized in the Prehospital Setting to Either Hypertonic Saline and Dextran Versus Normal Saline	Phase 2/Phase 3
Completed	`NCT03166722` - Cerebral Regional Tissue Oxygen Saturation to Guide Oxygen Delivery in Preterm Neonates During Immediate Transition	N/A
Not yet recruiting	`NCT04478812` - Tbit System Precision and Correlation of Different Blood Samples	N/A
Recruiting	`NCT05443542` - VIrtual Reality in Cognitive Rehabilitation of Processing Speed for Persons With ABI	N/A
Recruiting	`NCT05309005` - Virtual Reality and Social Cognition After Acquired Brain Injury
Completed	`NCT02702635` - Measuring Blood Flow Characteristics Using Dynamic Contrast Enhanced Magnetic Resonance Imaging	N/A
Withdrawn	`NCT04247321` - Non-invasive Near-infrared Spectroscopy (NIRS) Versus Invasive Licox Intracranial Pressure	N/A
Not yet recruiting	`NCT04386525` - Omega 3 and Ischemic Stroke; Fish Oil as an Option	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.